Unknown

Dataset Information

0

TFEB-NF-?B inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity.


ABSTRACT: BACKGROUND:Doxorubicin is effective in a variety of solid and hematological malignancies. Unfortunately, clinical application of doxorubicin is limited due to a cumulative dose-dependent cardiotoxicity. Dihydrotanshinone I (DHT) is a natural product from Salvia miltiorrhiza Bunge with multiple anti-tumor activity and anti-inflammation effects. However, its anti-doxorubicin-induced cardiotoxicity (DIC) effect, either in vivo or in vitro, has not been elucidated yet. This study aims to explore the anti-inflammation effects of DHT against DIC, and to elucidate the potential regulatory mechanism. METHODS:Effects of DHT on DIC were assessed in zebrafish, C57BL/6 mice and H9C2 cardiomyocytes. Echocardiography, histological examination, flow cytometry, immunochemistry and immunofluorescence were utilized to evaluate cardio-protective effects and anti-inflammation effects. mTOR agonist and lentivirus vector carrying GFP-TFEB were applied to explore the regulatory signaling pathway. RESULTS:DHT improved cardiac function via inhibiting the activation of M1 macrophages and the excessive release of pro-inflammatory cytokines both in vivo and in vitro. The activation and nuclear localization of NF-?B were suppressed by DHT, and the effect was abolished by mTOR agonist with concomitant reduced expression of nuclear TFEB. Furthermore, reduced expression of nuclear TFEB is accompanied by up-regulated phosphorylation of IKK?/? and NF-?B, while TFEB overexpression reversed these changes. Intriguingly, DHT could upregulate nuclear expression of TFEB and reduce expressions of p-IKK?/? and p-NF-?B. CONCLUSIONS:Our results demonstrated that DHT can be applied as a novel cardioprotective compound in the anti-inflammation management of DIC via mTOR-TFEB-NF-?B signaling pathway. The current study implicates TFEB-IKK-NF-?B signaling axis as a previously undescribed, druggable pathway for DIC.

SUBMITTER: Wang X 

PROVIDER: S-EPMC7245789 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity.

Wang Xiaoping X   Wang Qiyan Q   Li Weili W   Zhang Qian Q   Jiang Yanyan Y   Guo Dongqing D   Sun Xiaoqian X   Lu Wenji W   Li Chun C   Wang Yong Y  

Journal of experimental & clinical cancer research : CR 20200524 1


<h4>Background</h4>Doxorubicin is effective in a variety of solid and hematological malignancies. Unfortunately, clinical application of doxorubicin is limited due to a cumulative dose-dependent cardiotoxicity. Dihydrotanshinone I (DHT) is a natural product from Salvia miltiorrhiza Bunge with multiple anti-tumor activity and anti-inflammation effects. However, its anti-doxorubicin-induced cardiotoxicity (DIC) effect, either in vivo or in vitro, has not been elucidated yet. This study aims to exp  ...[more]

Similar Datasets

| S-EPMC9386238 | biostudies-literature
| S-EPMC8621765 | biostudies-literature
| S-EPMC7845587 | biostudies-literature
| S-EPMC4785358 | biostudies-literature
| S-EPMC3193406 | biostudies-other
| S-EPMC4815975 | biostudies-other
| S-EPMC10089821 | biostudies-literature
| S-EPMC7905261 | biostudies-literature
| S-EPMC6950076 | biostudies-literature
| S-EPMC7225962 | biostudies-literature